Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 418 is a nuclear DNA-binding transcriptional repressor belonging to the Krueppel C2H2-type zinc finger family. It is involved in the regulation of transcription mediated by RNA polymerase II, as well as in cellular protein degradation processes such as the ubiquitin-proteasome and autophagy-lysosomal pathways. There is limited evidence associating ZNF418 with diseases, with some implication in ovarian squamous cell carcinoma, but it is not currently recognized as a therapeutic target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 418 (ZNF418).